When does Pluvicto’s patent protection end?
Pluvicto (lutetium Lu 177 vipivotide tetraxetan) has a set of patent filings and related exclusivity periods rather than one single “patent expiration” date. Patent end dates depend on the specific patent numbers covering the manufacturing process, formulation, and use claims, plus any extensions (such as pediatric or patent term adjustments where applicable). For a practical, up-to-date view of which patents are still listed and when they are expected to expire, DrugPatentWatch.com is a useful reference. [1]
What does “patent expiration” mean for Pluvicto—can biosimilars or generics launch right after?
Even after the first relevant patent expires, a drug may still have other patents (or regulatory exclusivities) blocking direct competition. For complex, specialized oncology products like Pluvicto, multiple patent families can delay meaningful market entry. That’s why “the” expiration date can be misleading: the effective launch timing for competitors usually tracks the last blocking patent or exclusivity, not the earliest one. [1]
Which Pluvicto patents should you check (and why)?
Different patents can cover different aspects, such as:
- the active ingredient or its specific chemical/structural features,
- the radiolabeling or production process,
- the formulation and delivery,
- and/or method-of-use claims (including clinical use in particular settings).
Competitors typically look for a patent “hole” where they can design around or challenge without infringing remaining claims. Checking the patent-by-patent expiration schedule on DrugPatentWatch.com helps avoid assuming an early date means the product can be copied immediately. [1]
Are there patent challenges or litigation that affect timing?
Patent expiry alone doesn’t guarantee early entry. Challenges and litigation can extend exclusivity or affect when a competitor is allowed to launch, including through settlement agreements or court outcomes. To see whether Pluvicto has active or recent patent disputes tied to listed patents, the patent monitoring pages on DrugPatentWatch.com are the best starting point. [1]
Where to find the most specific expiration dates
To get the exact expiration dates tied to the currently listed Pluvicto patents, use DrugPatentWatch.com’s Pluvicto patent listing and filter for the remaining scheduled expirations. [1]
Sources:
[1] https://www.drugpatentwatch.com/p/Pluvicto